Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant
- 1 March 2000
- journal article
- Published by Springer Science and Business Media LLC in AAPS PharmSciTech
- Vol. 1 (1), 1-8
- https://doi.org/10.1007/bf02830516
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/ polyglycolic acid copolymersBiomaterials, 1996
- Biodegradable Microspheres in Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- LeuprorelinDrugs, 1994
- Sustained Pharmacological Activities in Rats Following Single and Repeated Administration of Once-a-Month Injectable Microspheres of Leuprolide AcetatePharmaceutical Research, 1991
- Pharmacokinetics of Once-a-Month Injectable Microspheres of Leuprolide AcetatePharmaceutical Research, 1991
- Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate CancerJournal of Urology, 1990
- Toxicity of N-methyl-2-pyrrolidone (NMP): Teratogenic, subchronic, and two-year inhalation studiesFundamental and Applied Toxicology, 1987
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerThe New England Journal of Medicine, 1984
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonistFertility and Sterility, 1982
- Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.Proceedings of the National Academy of Sciences of the United States of America, 1981